Comparison of the miR-23b and miR-203 Expressions in Endometrial Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
MicroRNAs (miRNAs/miRs) are a group of small noncoding RNAs that modulate gene expression. Many studies, demonstrating altered expressions of specific miRNAs in diverse types of human neoplasia, suggested that they may play a key role in tumorigenesis. Recently, miRNA genes were found to be abnormally expressed in several types of cancer, including endometrial cancer. However, miR-23b and miR-203 expression in endometrial cancer has yet to be studied in Korea. As such, the purpose of this study was to analyze miR-23b and miR-203 expressions in endometrial cancer and to evaluate the relationship between miR-23b and miR-203 expressions. A retrospective study was carried out on the formalin-fixed, paraffin-embedded tissues of 42 endometrial cancer tissues using quantitative real-time PCR. In endometrial cancer tissues, miR-23b expression levels (2.70±4.45) were higher than miR-203 expression levels (-2.34±4.08). Endometrial cancer tissues showed an overexpression of miR-23b in 30 (71.4%) of the 42 endometrial cancer cases, whereas miR-203 was underexpressed in 29 (69.0%) of the 42 cases. There was a significant association between miR-23b and miR-203 expressions in endometrial cancer tissues (p=0.0005). These findings suggest that miR-23b and miR-203 expressions may be involved in endometrial carcinogenesis. More studies are needed to further define the relationship between miR-23b and miR-203 expressions and tissue-specific protein expression.
Abstract
MicroRNAs (miRNAs/miRs) are a group of small noncoding RNAs that modulate gene expression. Many studies, demonstrating altered expressions of specific miRNAs in diverse types of human neoplasia, suggested that they may play a key role in tumorigenesis. Recently, miRNA genes were found to be abnormally expressed in several types of cancer, including endometrial cancer. However, miR-23b and miR-203 expression in endometrial cancer has yet to be studied in Korea. As such, the purpose of this study was to analyze miR-23b and miR-203 expressions in endometrial cancer and to evaluate the relationship between miR-23b and miR-203 expressions. A retrospective study was carried out on the formalin-fixed, paraffin-embedded tissues of 42 endometrial cancer tissues using quantitative real-time PCR. In endometrial cancer tissues, miR-23b expression levels (2.70±4.45) were higher than miR-203 expression levels (-2.34±4.08). Endometrial cancer tissues showed an overexpression of miR-23b in 30 (71.4%) of the 42 endometrial cancer cases, whereas miR-203 was underexpressed in 29 (69.0%) of the 42 cases. There was a significant association between miR-23b and miR-203 expressions in endometrial cancer tissues (p=0.0005). These findings suggest that miR-23b and miR-203 expressions may be involved in endometrial carcinogenesis. More studies are needed to further define the relationship between miR-23b and miR-203 expressions and tissue-specific protein expression.
참고문헌 (19)
- Banno K, "Endometrial cancer and hypermethylation: regulation of DNA and microRNA by epigenetics", Biochem Res Int, pp.738274~ (2012)[DOI]
- Poy MN, "A pancreatic islet-specific microRNA regulates insulin secretion", Nature, 432, pp.226~230 (2004)
- Qin X, "MicroRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer", Oncol Lett, 4(6), pp.1290~1296 (2012)
- Gilabert-Estelles J, "Role of microRNAs in gynecological pathology", Curr Med Chem, 19(15), pp.2406~2413 (2012)
- 최우순, "다발성골수종 환자의 파라핀포매조직에서 MicroRNA 발현", 대한임상검사과학회지, 47(4), pp.292~297 (2015), 대한임상검사과학회
- Yanokura M, "MicroRNA and endometrial cancer: roles of small RNAs in human tumors and clinical applications (Review)", Oncol Lett, 1(6), pp.935~940 (2010)
- Huang YW, "Hypermethylation of miR-203 in endometrial carcinomas", Gynecol Oncol, 133(2), pp.340~345 (2014)
- Castilla MÁ, "Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma", J Pathol, 223(1), pp.72~80 (2011)
- Lee H, "Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma", Mod Pathol, 25(11), pp.1508~1515 (2012)
- Ma G, "Upregulation of microRNA-23a", b promotes tumor progression and confers poor prognosis in patients with gastric cancer, 2014, pp.7(12), 8833~8840
- Shahana Majid, "MicroRNA-23b Functions as a Tumor Suppressor by Regulating Zeb1 in Bladder Cancer", PLoS ONE, 8(7), pp.e67686~ (2013), Public Library of Science (PLoS)[DOI]
- Li J, "miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression", Cancer Lett, 304(1), pp.52~59 (2011)
- Han C, "Role of microRNA-1 in human cancer and its therapeutic potentials", Biomed Res Int, pp.428371~ (2014)[DOI]
- Mohd Saif Zaman, "Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal Cancer", PLoS ONE, 7(11), pp.e50203~ (2012), Public Library of Science (PLoS)[DOI]
- Majid S, "miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer", Cancer Res, 72(24), pp.6435~6446 (2012)
- Furuta M, "MiR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma", Carcinogenesis, 31(5), pp.766~776 (2010)
- Chiang Y, "Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers", J Gastrointest Surg, 15(1), pp.63~70 (2011)
- X J Li, "MicroRNA-34a: a potential therapeutic target in human cancer", Cell Death & Disease, 5(7), pp.e1327~e1327 (2014), Springer Nature[DOI]
- Bueno MJ, "Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression", Cancer Cell, 13(6), pp.496~506 (2008)